Panagora Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,328
| Closed | -$347K | – | 1248 |
|
|
2024
Q1 | $347K | Buy |
15,328
+165
| +1% | +$3.74K | ﹤0.01% | 1045 |
|
|
2023
Q4 | $197K | Buy |
+15,163
| New | +$197K | ﹤0.01% | 1183 |
|
|
2021
Q1 | – | Sell |
-3,450
| Closed | -$801K | – | 2870 |
|
|
2020
Q4 | $801K | Hold |
3,450
| – | – | ﹤0.01% | 1057 |
|
|
2020
Q3 | $756K | Hold |
3,450
| – | – | ﹤0.01% | 999 |
|
|
2020
Q2 | $980K | Sell |
3,450
-2,644
| -43% | -$751K | 0.01% | 942 |
|
|
2020
Q1 | $1.76M | Buy |
+6,094
| New | +$1.76M | 0.01% | 631 |
|
|
2019
Q1 | – | Sell |
-6,728
| Closed | -$946K | – | 2536 |
|
|
2018
Q4 | $946K | Sell |
6,728
-283
| -4% | -$39.8K | ﹤0.01% | 1100 |
|
|
2018
Q3 | $1.79M | Sell |
7,011
-8,503
| -55% | -$2.17M | 0.01% | 882 |
|
|
2018
Q2 | $3.95M | Buy |
15,514
+5,513
| +55% | +$1.41M | 0.02% | 617 |
|
|
2018
Q1 | $2.01M | Buy |
10,001
+206
| +2% | +$41.5K | 0.01% | 872 |
|
|
2017
Q4 | $1.41M | Buy |
9,795
+4,575
| +88% | +$659K | 0.01% | 1017 |
|
|
2017
Q3 | $860K | Buy |
5,220
+1,112
| +27% | +$183K | ﹤0.01% | 1179 |
|
|
2017
Q2 | $558K | Buy |
+4,108
| New | +$558K | ﹤0.01% | 1316 |
|
|
2016
Q1 | – | Sell |
-121
| Closed | -$24K | – | 2316 |
|
|
2015
Q4 | $24K | Sell |
121
-31
| -20% | -$6.15K | ﹤0.01% | 2120 |
|
|
2015
Q3 | $24K | Buy |
+152
| New | +$24K | ﹤0.01% | 2114 |
|
|
2014
Q4 | – | Sell |
-62
| Closed | -$32K | – | 2314 |
|
|
2014
Q3 | $32K | Hold |
62
| – | – | ﹤0.01% | 2097 |
|
|
2014
Q2 | $43K | Sell |
62
-3
| -5% | -$2.08K | ﹤0.01% | 2127 |
|
|
2014
Q1 | $30K | Buy |
+65
| New | +$30K | ﹤0.01% | 2171 |
|